Cytokinetics
CYTK
$65.34
Share price
0.83%
Change (1 day)
74.71%
Change (1 year)
Categories
Number of shares outstanding for Cytokinetics (CYTK)
Number of shares outstanding as of April 2024 : 99,067,000
According to Cytokinetics 's latest financial reports and stock price the company's current number of shares outstanding is 99,067,000. At the end of 2023 the company had 99,067,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Cytokinetics from 2013 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 99.06 M | 4.63% |
| 2022 | 94.68 M | 12.6% |
| 2021 | 84.08 M | 18.71% |
| 2020 | 70.83 M | 20.79% |
| 2019 | 58.64 M | 7.22% |
| 2018 | 54.68 M | 1.41% |
| 2017 | 53.92 M | 32.89% |
| 2016 | 40.58 M | 3.79% |
| 2015 | 39.09 M | 6.39% |
| 2014 | 36.74 M | 23.17% |
| 2013 | 29.83 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 535,000,000 | 440.04% | 🇺🇸 USA |
 Trevena TRVN | 13,964,301 | -85.90% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 17,380,000 | -82.46% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 1,242,000 | -98.75% | 🇺🇸 USA |
 Array Technologies ARRY | 151,175,000 | 52.60% | 🇺🇸 USA |